Methodenwebinare

ROB-ME: a tool for assessing risk of non-reporting biases in systematic reviews with meta-analysis

Dr. Matthew Page (Senior Research Fellow, Methods in Evidence Synthesis Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia)

LIGHTS (www.lights.science) - a searchable database for methods guidance

Stefan Schandelmaier, MD PhD, (Division of Clinical Epidemiology, Department of Clinical Research, University of Basel, Switzerland)

Introducing the LATITUDES NETWORK: Ensuring Study Validity to Inform Health Technology Assessments Globally

Beth Devine, PhD, PharmD, MBA (Professor and Associate Director, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington)

Empirical heterogeneity priors for Bayesian random-effects meta-analyses with very few studies

Prof. Dr. Ralf Bender (Head of Department "Medical Biometry", independent Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG), Germany)

CAMELOT: A new approach for assessing methodological limitations of qualitative research

Dr. Heather Menzies Munthe-Kaas (Researcher at the Centre for Epidemic Interventions Research at the Norwegian Institute of Public Health)

Living Systematic Review methodology - challenges and lessons learned from the pandemic

Dr. Claire Iannizzi (Researcher at Institute of Public Health, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany)

"Making health evidence relevant, accessible and trustworthy. Why and how to involve patients & carers in systematic reviews”

Richard Morley (Consumer Engagement Officer, Cochrane UK, and Maureen Smith, Chair of Cochrane’s Consumer Executive)

"metaHelper: a tool to transform statistical measures used for meta-analysis”

Robert Emprechtinger (Statistician at the Faculty of Health and Medicine, University of Krems, Austria)

"Study with a review (SWAR): An introduction”

Prof. Declan Devane (Director of Evidence Synthesis Ireland and Director of Cochrane, Professor of Health Research Methodology and Deputy Dean of the College of Medicine, Nursing and Health Sciences at University of Galway)

“An introduction and overview of scoping reviews”

Dr. Zachary Munn (Director of Health Evidence Synthesis, Recommendations and Impact (HESRI) in the School of Public Health at the University of Adelaide)

“Assessing harms in systematic reviews”

Dr. Evan Mayo-Wilson (Associate Professor in the Department of Epidemiology at the University of North Carolina Gillings School of Global Public Health)

Beyond statistical significance: how systematic review authors communicate meaningful differences of statistically nonsignificant results 

Dr. Emma Persad (Doctoral Student and Clinical Research Coordinator in the Department of Women’s and Children’s Health at Karolinska Institute, Sweden; Cochrane Governing Board member)

Synthesis and presentation of results when meta-analysis is not possible

Joanne McKenzie (Professor of Biostatistics and Head of the Methods in Evidence Synthesis Unit at the School of Public Health and Preventive Medicine, Monash University)

Link zum Video

Methods for deriving risk difference (absolute risk reduction) from a meta-analysis

M. Hassan Murad, MD, MPH, (Professor of Medicine and Director of Evidence-based Practice Center, Mayo Clinic in Rochester, MN)

“Real world implementation trials”

Robby Foy (Professor of Primary Care at the University of Leeds, UK)

"Is the subgroup effect credible? Introducing the ICEMAN tool"

Stefan Schandelmaier, MD PhD (Assistant Professor at McMaster University, Hamilton, Canada and Senior Researcher at University of Basel, Switzerland)

"Use of preprints in prevention research: a mixed methods study"

Isolde Sommer (Assistant-Professor at the Department for Evidence-based Medicine and Evaluation, University for Continuing Education Krems, Austria)

"Missing data in meta-analysis (do’s and don'ts)"

Lotty Hooft (Cochrane Netherlands, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands)

"Living systematic reviews: exploring their rapid rise"

Dr. Anneliese Synnot (Research Fellow, Cochrane Australia, Monash University)

"Public Health England rapid reviews during COVID-19”

Marialena Trivella (Honorary Senior Researcher at Oxford University Medical Sciences Division and Cochrane Statistical Editor - Injuries Group, London School of Hygiene and Tropical Medicine, UK)

Managing, Registering, and Sharing Data with OSF

Eric Olson (Institutional  Product Owner at Center for Open Science)

Choose, Snooze or Lose? Selecting appropriate methods for Qualitative Evidence Synthesis

Dr. Andrew Booth (School of Health and Related Research at the University of Sheffield)

Assessing equity in systematic reviews: a systems perspective

Mark Petticrew, BA PhD (Professor of Public Health Evaluation, London School of Hygiene & Tropical Medicine)

L·OVE: the Epistemonikos' platform that eradicates search and screening

Gabriel Rada (Founder and chairman at Epistemonikos foundation)

CONSENSYS - an instrument to formulate context sensitive implication sections in systematic reviews

Theresa Bengough (PhD researcher at the Catholic University Leuven)

Crowdsourcing in health evidence production

Anna Noel-Storr (Information Specialist for the Cochrane Dementia and Cognitive Improvement Group)

Major challenge in overviews of reviews: overlapping primary studies across reviews

Dawid Pieper (Professor, Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane

Evidence Identification in Systematic Reviews

Dr. Michael Gusenbauer

(Post-Doc Researcher, University of Innsbruck)

Rapid Review Methods - current insights

Dr. Barbara Nußbaumer-Streit, MSc BSc Bakk

(Donau-Universität Krems)

Influence of different mortality time points on pooled effect estimates

Dominik Roth (Medizinische Universität Wien)

What Makes Realist Reviews Realist? - A Rapid-Fire Introduction

Gill Westhorp, PhD (Professorial Research Fellow at Charles Darwin University)

Definition of the Fragility Index of meta-analyses

Ignacio Atal, PhD (Center for Research and Interdisciplinarity (CRI) , Université de Paris, INSERM U1284)

^{Publikation: Atal I, Porcher R, Boutron I, Ravaud P. The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses. J Clin Epidemiol 2019;111:32-40. doi: https://doi.org/10.1016/j.jclinepi.2019.03.012}

^{Link zum Webtool: http://clinicalepidemio.fr/fragility_ma/}

Cochrane's Dissemination Checklist: Methods for effectively sharing your review results

Stephanie Lagosky (Knowledge Translation Project Officer at Cochrane)

Guidance for identifying trial participants with missing data

Lara Kahale (American University of Beirut medial Center)

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Dr. Matthew Page, PhD (Senior Research Fellow and ARC DECRA Fellow from Monash University in Melbourne, Australia)